Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Leenders, K.L.
Gibbs, J.M.
Frackowiak, R.S.J.
Lammertsma, A.A.
and
Jones, T.
1984.
Positron emission tomography of the brain: new possibilities for the investigation of human cerebral pathophysiology.
Progress in Neurobiology,
Vol. 23,
Issue. 1-2,
p.
1.
1984.
Parkinson's Disease, 1984.
The Lancet,
Vol. 323,
Issue. 8381,
p.
829.
Heiss, Wolf-Dieter
Beil, Curt
Herholz, Karl
Pawlik, Günter
Wagner, Rainer
and
Wienhard, Klaus
1985.
Atlas der Positronen-Emissions-Tomographie des Gehirns / Atlas of Positron Emission Tomography of the Brain.
p.
105.
Martin, W. R. Wayne
1985.
Positron Emission Tomography in Movement Disorders.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 12,
Issue. 1,
p.
6.
Calne, D. B.
Langston, J. William
Martin, W. R. Wayne
Stoessl, A. Jon
Ruth, Thomas J.
Adam, Michael J.
Pate, Brian D.
and
Schulzer, Michael
1985.
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.
Nature,
Vol. 317,
Issue. 6034,
p.
246.
Creveling, Cyrus R.
and
Kirk, Kenneth L.
1985.
The effect of ring-fluorination on the rate of O-methylation of dihydroxyphenylalanine (DOPA) by catechol-O-methyltransferase: Significance in the development of 18F-pett scanning agents.
Biochemical and Biophysical Research Communications,
Vol. 130,
Issue. 3,
p.
1123.
Chiueh, C.C.
Burns, R.S.
Markey, S.P.
Jacobowitz, D.M.
and
Kopin, I.J.
1985.
III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
Life Sciences,
Vol. 36,
Issue. 3,
p.
213.
Heiss, Wolf-Dieter
Beil, Curt
Herholz, Karl
Pawlik, Günter
Wagner, Rainer
and
Wienhard, Klaus
1985.
Atlas der Positronen-Emissions-Tomographie des Gehirns / Atlas of Positron Emission Tomography of the Brain.
p.
117.
Leenders, K. L.
Poewe, W. H.
Palmer, A. J.
Brenton, D. P.
and
Frackowiak, R. S. J.
1986.
Inhibition of L‐{18F}fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography.
Annals of Neurology,
Vol. 20,
Issue. 2,
p.
258.
Newman, Richard P.
and
Calne, Donald B.
1986.
Movement Disorders.
p.
39.
Gotham, A.-M.
Brown, R.G.
and
Marsden, C.D.
1986.
LEVODOPA TREATMENT MAY BENEFIT OR IMPAIR "FRONTAL" FUNCTION IN PARKINSON'S DISEASE.
The Lancet,
Vol. 328,
Issue. 8513,
p.
970.
Syrota, André
1986.
In vivo study of receptors for neuromediators with pet.
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology,
Vol. 13,
Issue. 2,
p.
127.
Nahmias, C.
and
Garnett, E. S.
1986.
Pictorial Information Systems in Medicine.
p.
507.
Harvey, Norman S.
1986.
Psychiatric disorders in parkinsonism: 1. Functional illnesses and personality.
Psychosomatics,
Vol. 27,
Issue. 2,
p.
91.
Frost, J.James
1986.
Imaging neuronal biochemistry by emission computed tomography: focus on neuroreceptors.
Trends in Pharmacological Sciences,
Vol. 7,
Issue. ,
p.
490.
Stöcklin, Gerhard
1986.
Molecules labeled with positron emitting halogens.
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology,
Vol. 13,
Issue. 2,
p.
109.
Firnau, Gunter
Garnett, E.S.
Chirakal, Raman
Sood, Sudesh
Nahmias, Claude
and
Schrobilgen, Gary
1986.
[18F]Fluoro-l-dopa for the in vivo study of intracerebral dopamine.
International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes,
Vol. 37,
Issue. 8,
p.
669.
Cummings, J. L.
1986.
Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology.
British Journal of Psychiatry,
Vol. 149,
Issue. 6,
p.
682.
Bulens, C.
Meerwaldt, J. D.
Van der Wildt, G. J.
and
Van Deursen, J. B. P.
1987.
Effect of levodopa treatment on contrast sensitivity in Parkinson's disease.
Annals of Neurology,
Vol. 22,
Issue. 3,
p.
365.
Cumming, Paul
Boyes, Barry E.
Martin, W.R.Wayne
Adam, Michael
Ruth, Thomas J.
and
McGeer, Edith G.
1987.
Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.
Biochemical Pharmacology,
Vol. 36,
Issue. 15,
p.
2527.